SHL Telemedicine is a global leader in telemedicine technologies and services. They develop innovative technologies, solutions, and advanced telemedicine services for diagnosing and monitoring various chronic diseases, with a focus on the heart. With vast experience in remote medical services, SHL is a leading telemedicine provider in Israel and Germany.

Their 24/7 telemedicine centers in Israel and Germany, based on cloud technology, facilitate about 3 million medical interactions every year. One of the key products they offer is a hospital-grade mobile 12-lead ECG device, which is FDA cleared. It is the only mobile device of its kind for personal use.

SHL Telemedicine strives to accelerate its global telemedicine operations by implementing proven technologies and services. They utilize artificial-intelligence (A. I) technology and large databases (Big-Data) to enhance their offerings.

They also collaborate with leading strategic healthcare partners to further expand their reach. With a focus on growth potential, SHL Telemedicine collaborates with renowned healthcare institutions like Mayo Clinic. They work with OTC and private customers, retail chains and distributors, as well as clinics and nursing homes to provide comprehensive telemedicine solutions.

Stay updated with SHL Telemedicine's latest news and achievements through their informative website. They continue to expand their markets in Israel, Germany, and the USA, offering innovative telemedicine solutions for improved healthcare outcomes